The clinical challenge of chronic neuropathic pain

Disability and Rehabilitation

Volumn 28, Issue 6, 2006, Pages 343-349

  Vissers, Kris C P ^a,b  

^a Intensive Care Medicine   (Belgium)

^b NONE   (Belgium)

Author keywords

Aetiology diagnosis; Neuropathic pain; Pathophysiology; Work out

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA ADRENERGIC RECEPTOR; AMPA RECEPTOR; ANTIVIRUS AGENT; CALCITONIN GENE RELATED PEPTIDE; CHEMOTACTIC FACTOR; GLUTAMIC ACID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NERVE GROWTH FACTOR; NORADRENALIN; OPIATE RECEPTOR; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA;

CANCER CHEMOTHERAPY; CANCER PAIN; CEREBROVASCULAR ACCIDENT; CHRONIC PAIN; CLINICAL FEATURE; CYTOKINE PRODUCTION; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE EXACERBATION; ELECTROMYOGRAPHY; ELECTRONEUROGRAPHY; EVOKED RESPONSE; GLIA CELL; HERPES ZOSTER; HUMAN; MULTIPLE SCLEROSIS; NERVE BLOCK; NERVE FIBER DEGENERATION; NERVE INJURY; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPATHIC PAIN; NOCICEPTION; NORADRENALIN RELEASE; OPPORTUNISTIC INFECTION; PATHOPHYSIOLOGY; PHANTOM PAIN; PRIORITY JOURNAL; RADIATION INJURY; REVIEW; SCHWANN CELL; SPINAL CORD INJURY; SURGICAL INJURY; SYRINGOMYELIA; THERMOGRAPHY; VIRUS INFECTION; VISCERAL PAIN;

CHRONIC DISEASE; HUMANS; HYPERALGESIA; HYPERESTHESIA; NEURALGIA; PAIN MEASUREMENT; PERIPHERAL NERVES; PERIPHERAL NERVOUS SYSTEM DISEASES; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION;

EID: 33644587462     PISSN: 09638288     EISSN: 14645165     Source Type: Journal    
DOI: 10.1080/09638280500287270     Document Type: Review

References (40)

1. Myers, R and Wagner, R and Sorkin, L.(1999) Hyperalgesic actions of cytokines on peripheral nerves. In Cytokines and Pain. (pp. 133 - 158). Basel: Birkhäuser.
2. Janig, W and Baron, R. (2003) Complex regional pain syndrome: Mystery explained? Lancet Neurol, 2, pp. 687 - 697.
3. Loeser, J. (1999) Economic implications of pain management Acta Anaesthesiol Scand, 43, pp. 957 - 959.
4. Jacobson, L and Mariano, A.(2001) General considerations of chronic pain. Philadelphia: Lippincott Williams & Wilkins.
5. Reginster, J and Khaltaev, N. (2002) Introduction and WHO perspective on the global burden of musculoskeletal conditions Rheumatol (Oxford), 1(Suppl. 41), pp. 1 - 2.
6. van Tulder, M and Koes, B and Bombardier, C. (2002) Low back pain Best Pract Res Clin Rheumatol, 16, pp. 761 - 775.
7. Cervero, F and Laird, J. (1996) From acute to chronic pain: Mechanisms and hypotheses Prog Brain Res, 110, pp. 3 - 15.
8. Bonica, J. (1990) General consideration of chronic pain. In The management of pain, (pp. 241 - 254) Philadelphia: Lea & Febiger.
9. Aguggia, M. (2003) Neurophysiology of pain Neurol Sci, 24(Suppl. 2), pp. S57 - S60.
10. Merskey, H and Bogduk, N.(1994) Classification of chronic pain: Descriptions of chronic pain syndromes and definitions of pain terms. 2nd ed. Seattle WA: IASP Press.
11. Zeltser, R and Seltzer, Z.(1994) A practical guide for the use of animal models in the study of neuropathic pain. In Touch, temperature and pain in health and disease: Mechanisms and assessments. (pp. 295 - 338). Seattle WA: IASP Press.
12. Kontinen, V. (1998) Spinal pharmacology of pain: Actions and interactions of μ-opioids, α-adrenergic agonists and neuropeptide FF in different models of pain in rats Helsinki, pp. 24. ISBN 952 90 9626 2;
13. Watkins, L. and Maier, S. (2002) Beyond neurons: Evidence that immune and glial cells contribute to pathological pain states Physiol Rev, 82, pp. 981 - 1011
14. Enggaard, T and Klitgaard, N and Gram, L and Arendt-Nielsen, L and Sindrup, S. (2001) Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans Clin Pharmacol Ther, 69, pp. 245 - 251.
15. Hoitsma, E and Reulen, J and de Baets, M and Drent, M and Spaans, F and Faber, C. (2004) Small fiber neuropathy: A common and important clinical disorder J Neurol Sci, 227, pp. 119 - 130.
16. Koltzenburg, M.(2002) Classification of neuropathic pain. In Pain 2002 - An updates review: Refresher Course Syllabus. (pp. 149 - 151). Seattle WA: IASP Press.
17. Ossipov, M. and Lai, J and Malan, T. Jr and Porreca, F. (2000) Spinal and supraspinal mechanisms of neuropathic pain Ann NY Acad Sci, 909, pp. 12 - 24.
18. Patten, J.(1995) Neurological differential diagnosis. Springer Verlag.
19. Yasuda, H and Terada, M and Maeda, K and Kogawa, S and Sanada, M and Haneda, M and Kashiwagi, A and Kikkawa, R. (2003) Diabetic neuropathyandnerve regeneration Prog Neurobiol, 69, pp. 229 - 285.
20. Schmader, K. (2002) Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy Clin J Pain, 18, pp. 350 - 354.
21. Luciano, C and Pardo, C and McArthur, J. (2003) Recent developments in the HIV neuropathies Curr Opin Neurol, 16, pp. 403 - 409.
22. Vielhaber, A and Portenoy, R. (2002) Advances in cancer pain management Hematol Oncol Clin North Am, 16, pp. 527 - 541.
23. Siddall, P and Taylor, D and Cousins, M. (1997) Classification of painfollowing spinal cord injury Spinal Cord, 35, pp. 69 - 75.
24. Backonja, M. (2000) Anticonvulsants (antineuropathics) for neuropathic pain syndromes Clin J Pain, 16, pp. S67 - S72.
25. Bennett, G.(1997) Neuropathic pain: An overview. In Molecular Neurobiology of pain. Seattle WA: IASP Press.
26. Asbury, A.(1998) Disorders of nerve and muscle. In Harrinson's principles of internal medicine. (pp. 2457 - 2469). New York: McGraw-Hill.
27. Attal, N. (2000) Chronic neuropathic pain: Mechanisms and treatment Clin J Pain, 16, pp. S118 - S130.
28. Hansson, P. (1994) Possibilities and potential pitfalls of combined bedside and quantitative somatosensory analysis in pain patients. In Touch, temperature and pain in health and disease: Mechanisms and assessments, progress in pain research and management. (pp. 113 - 132). Seattle WA: IASP Press.
29. Korovessis, P and Dimas, A and Lambiris, E. (2002) The significance of correlation of radiographic variables and MOS short-form health survey for clinical decision in symptomatic low backpain patients Stud Health Technol Inform, 91, pp. 325 - 331.
30. Mao, J and Chen, L. (2000) Systemic lidocaine for neuropathic pain relief Pain, 87, pp. 7 - 17.
31. McLachlan E. and Janig W. and Devor M. and Michaelis M. (1993) Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia Nature, 363, pp. 543 - 546.
32. Woolf, C and Mannion, R. (1999) Neuropathic pain: Aetiology, symptoms, mechanisms and management Lancet, 353, pp. 1959 - 1964.
33. Bredt, D and Nicoll, R. (2003) AMPA receptor trafficking at excitatory synapses Neuron, 40, pp. 361 - 379.
34. Woolf, C and Thompson, S. (1991) The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states Pain, 44, pp. 293 - 299.
35. Woolf, C and Doubell, T. (1994) The pathophysiology of chronic pain-increased sensitivity to low threshold A beta-fibre inputs Curr Opin Neurobiol, 4, pp. 525 - 534.
36. Neumann, S and Doubell, T and Leslie, T and Woolf, C. (1996) Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons Nature, 384, pp. 360 - 364.
37. Reynolds, M and Woolf, C. (1993) Reciprocal Schwann cell-axon interactions Curr Opin Neurobiol, 3, pp. 683 - 693.
38. Muller, H and Stoll, G. (1998) Nerve injury and regeneration: Basic insights and therapeutic interventions Curr Opin Neurol, 11, pp. 557 - 562.
39. Watkins, L and Milligan, E and Maier, S. (2003) Glial proinflammatory cytokines mediate exaggerated pain states: Implications for clinical pain Adv Exp Med Biol, 521, pp. 1 - 21.
40. Dinarello, C. (1999) Overview of inflammatory cytokines and their role in pain. In Cytokines and Pain pp. 1-19